Susan K. Finston
This article is part of the Pharma_Portal project of Spinwatch. |
Susan K. Finston is the President of Finston Consulting LLC and works with a wide range of clients on legal, transactional, policy and "doing business" issues relating to the innovative life sciences. Since 2005, she has been the Executive Director of the Access and Benefit Sharing Alliance (ABSA). She is also a founding Board Member of BayhDole25. Finston serves as Convenor of the Washington Embassy Network (WEN)and has previously served as Associate Vice President for Intellectual Property, Middle East, Africa and South Asian Affairs at the Pharmaceutical Research and Manufacturers of America (PhRMA). From 1986 through 1999, Susan worked for the U.S. Government, including 11 years in the U.S. Foreign Service, with assignments in London, Tel Aviv and Manila, where she specialized in intellectual property, trade and development issues. She served in the judicial branch of the U.S. Government for two years as a Motions Clerk at the federal Court of Appeals for the Seventh Circuit.[1] Finston is a research associate at the US’s Institute for Policy Innovation.<ref>Finston, S. K. [http://www.ipi.org/ipi/IPIPressReleases.nsf/23dfbb67b152cfdc86256c75007ee9e0/c06b446a1c50ff81852570a500488b47?OpenDocument Europe Starves Developing Nation Innovation]. Published in Financial Times on 25 October 2005.
Notes
- ↑ Finston Consulting About Finston Consulting Accessed on 26 October 2009.